Rapport Therapeutics, Inc. <RAPP.O>: Raymond James Raises Target Price to $75 From $68
RAPP•Related News
Newmont <NEM.N>: BofA Global Research Raises Price Objective to $145 From $135
NEM•
Enhertu Demonstrated Statistically Significant And Clinically Meaningful Improvement In Pfs
AZN•
Mobilicom eyes upside as Trump tariffs hit foreign drones, components up to 100%
MOB•
Cloudastructure Q2 FY26 net loss narrows to $1.7 million; revenue rises 13% to $1.2 million
CSAI•
Zenatech sees edge as US Section 232 tariffs hit imported drones up to 100%
ZENA•